Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Hyperglycemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia 2Leukemia, Myeloid, Acute 1Diabetes Mellitus, Type 2 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

fludarabine phosphate 63Peripheral Blood Stem Cell Transplantation 54Cyclophosphamide 52Mycophenolic Acid 43Tacrolimus 42Busulfan 42Cyclosporine 34Methotrexate 31Antilymphocyte Serum 31Whole-Body Irradiation 29Melphalan 22Radiotherapy 21Filgrastim 20Etoposide 18Cytarabine 17Cord Blood Stem Cell Transplantation 16Methylprednisolone 14Flow Cytometry 14Transplantation 11Psychiatric Rehabilitation 9Polymerase Chain Reaction 9sargramostim 8Therapeutics 8Alemtuzumab 8Thiotepa 7merphos 6Sirolimus 6Immunoenzyme Techniques 6thymoglobulin 5Vorinostat 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × Insulin Glargine × Lymphoid × Clear all
NCT00943709 2013-08-30

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Rutgers, The State University of New Jersey

Phase 3 Withdrawn
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Hyperglycemia, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡